Over at Chardan Capital, Geulah Livshits reiterated a buy rating and a $25 price target on July 23. From the stock's price of ...

Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...

The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial units to ...

A symbol began appearing across the walls of Germany near the end of World War II. It looked like a hastily drawn swastika ...

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of ...

LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong ...

Hapbee Technologies, Inc. (TSXV: HAPB) (OTC: HAPBF), the digital wellness company helping users feel better without ingesting substances, proudly announces the ...

Company: St. James Gold Corp. TSX-Venture Symbol: LORD All Issues: Yes Resumption (ET): 9:30 AM CIRO can make a decision to impose a ...